Stock Insights: Netflix, Melco Crown, Zynga, Illumina, Health Management April 24th

Netflix, Inc. (NASDAQ:NFLX): Cowen said Netflix delivered solid Q1 results and said concerns over Q2 subscriber growth are likely overdone. The firm cited its positive cash flow, international growth, and domestic DVD subscriber growth slowing slower than expected. Shares remain Neutral rated.

Melco Crown Entertainment Ltd. (NASDAQ:MPEL): Wells Fargo expects Melco to report higher than expected Q1 net EBITDA, and the firm thinks that the company is continuing to gain a significant amount of market share. The firm maintains an Outperform rating on the stock.

Zynga (NASDAQ:ZNGA): Baird said Zynga remains well positioned in the social and gaming markets following yesterday’s SEC filing by Facebook. The firm’s analysis showed potential risk to Zynga’s revenues from Facebook but saw faster growth in other platforms to offset its revenue decline. Shares remain Neutral rated with a $14 price target.

Illumina Inc. (NASDAQ:ILMN): Baird raised its price target on Illumina following solid Q1 results. The firm cited its consumer revenues growth, positive tone on end markets and pipeline, and reaffirmed conservative guidance. Shares are Outperform rated.

Health Management Associates Inc. (NYSE:HMA): After Health Management reported higher than expected Q1 adjusted EPS, Oppenheimer thinks that the company reported solid results. The firm maintains an Outperform rating on the shares.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.